Home » Topics » BioWorld Science

BioWorld Science
RSS

Nektar Therapeutics presents preclinical data on NKTR-255

April 28, 2022

WVE-004 shows promise for treating C9orf72-associated neurologic disorders

April 27, 2022

CIDRAP receives funding to create coronavirus vaccines R&D roadmap

April 27, 2022

PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403

April 27, 2022

Virpax reports preclinical PK results for VRP-324 for management of seizures

April 27, 2022

Algernon's NP-251 shown to reduce fibrosis in preclinical NASH study

April 27, 2022

NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers

April 27, 2022

ECCMID 2022: In antibiotic development, scientific ingenuity meets a dysfunctional marketplace

April 27, 2022

AstraZeneca presents new PROTACs for cancer

April 27, 2022

Cullgen identifies new PROTACs

April 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...